{"id":"https://openalex.org/W2884872702","doi":"https://doi.org/10.1038/s41417-018-0038-x","title":"Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401","display_name":"Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401","publication_year":2018,"publication_date":"2018-07-19","ids":{"openalex":"https://openalex.org/W2884872702","doi":"https://doi.org/10.1038/s41417-018-0038-x","mag":"2884872702","pmid":"https://pubmed.ncbi.nlm.nih.gov/30057416"},"language":"en","primary_location":{"id":"doi:10.1038/s41417-018-0038-x","doi":"https://doi.org/10.1038/s41417-018-0038-x","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41417-018-0038-x","pdf_url":null,"source":{"id":"https://openalex.org/S157451995","display_name":"Cancer Gene Therapy","issn_l":"0929-1903","issn":["0929-1903","1476-5500"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Gene Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035158988","display_name":"\u0141ukasz Kuryk","orcid":"https://orcid.org/0000-0003-1887-6361","observed_orcids":["https://orcid.org/0000-0003-1887-6361"]},"institutions":[{"id":"https://openalex.org/I4210101740","display_name":"Narodowy Instytut Zdrowia Publicznego PZH \u2013 Pa\u0144stwowy Instytut Badawczy","ror":"https://ror.org/015qjap30","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210101740"]},{"id":"https://openalex.org/I4210129595","display_name":"Targovax (Finland)","ror":"https://ror.org/033q3j448","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210129595","https://openalex.org/I4210158062"]}],"countries":["FI","PL"],"is_corresponding":true,"raw_author_name":"Lukasz Kuryk","raw_affiliation_strings":["Department of Virology, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. lukasz.kuryk@targovax.com","Targovax Oy, Clinical Science, Helsinki, Finland. lukasz.kuryk@targovax.com","Targovax Oy, Clinical Science, Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0003-1887-6361","affiliations":[{"raw_affiliation_string":"Department of Virology, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. lukasz.kuryk@targovax.com","institution_ids":["https://openalex.org/I4210101740"]},{"raw_affiliation_string":"Targovax Oy, Clinical Science, Helsinki, Finland. lukasz.kuryk@targovax.com","institution_ids":["https://openalex.org/I4210129595"]},{"raw_affiliation_string":"Targovax Oy, Clinical Science, Helsinki, Finland","institution_ids":["https://openalex.org/I4210129595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055496818","display_name":"Anne\u2010Sophie W. M\u00f8ller","orcid":"https://orcid.org/0009-0007-4507-1055","observed_orcids":["https://orcid.org/0009-0007-4507-1055"]},"institutions":[{"id":"https://openalex.org/I4210158062","display_name":"Targovax (Norway)","ror":"https://ror.org/05nkrhe64","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210158062"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Anne-Sophie W. M\u00f8ller","raw_affiliation_strings":["Targovax ASA, Clinical Science, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Targovax ASA, Clinical Science, Oslo, Norway","institution_ids":["https://openalex.org/I4210158062"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007152348","display_name":"Magnus Erik Jaderberg","orcid":"https://orcid.org/0000-0003-1917-1996","observed_orcids":["https://orcid.org/0000-0003-1917-1996"]},"institutions":[{"id":"https://openalex.org/I4210158062","display_name":"Targovax (Norway)","ror":"https://ror.org/05nkrhe64","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210158062"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Magnus Jaderberg","raw_affiliation_strings":["Targovax ASA, Clinical Science, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Targovax ASA, Clinical Science, Oslo, Norway","institution_ids":["https://openalex.org/I4210158062"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5035158988"],"corresponding_institution_ids":["https://openalex.org/I4210101740","https://openalex.org/I4210129595"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":1.5724,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.82968525,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"26","issue":"1-2","first_page":"26","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd40-ligand","display_name":"CD40 ligand","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.8420000076293945},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9739999771118164},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.8214234113693237},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.6926007270812988},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.5730443000793457},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5694748163223267},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45056524872779846},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.448012113571167},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.4289100170135498},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4241040349006653},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35385048389434814},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2970239222049713},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2914377450942993},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24951636791229248},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17414814233779907},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16476592421531677},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.15371260046958923},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.13808542490005493},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12337759137153625}],"mesh":[{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000469","descriptor_name":"Alkaline Phosphatase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023201","descriptor_name":"CD40 Ligand","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D023201","descriptor_name":"CD40 Ligand","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/s41417-018-0038-x","doi":"https://doi.org/10.1038/s41417-018-0038-x","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41417-018-0038-x","pdf_url":null,"source":{"id":"https://openalex.org/S157451995","display_name":"Cancer Gene Therapy","issn_l":"0929-1903","issn":["0929-1903","1476-5500"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Gene Therapy","raw_type":"journal-article"},{"id":"pmid:30057416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30057416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer gene therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7014093045","display_name":"ADenoViruses as novel clinical treatments","funder_award_id":"290002","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W234326522","https://openalex.org/W1974721375","https://openalex.org/W1975257938","https://openalex.org/W1978115937","https://openalex.org/W1995757311","https://openalex.org/W2023923918","https://openalex.org/W2065968189","https://openalex.org/W2067680656","https://openalex.org/W2099803230","https://openalex.org/W2107245918","https://openalex.org/W2109044040","https://openalex.org/W2120492514","https://openalex.org/W2124904564","https://openalex.org/W2137268127","https://openalex.org/W2142711009","https://openalex.org/W2147321531","https://openalex.org/W2167259834","https://openalex.org/W2417595100","https://openalex.org/W2418173502"],"related_works":["https://openalex.org/W2123182549","https://openalex.org/W2002143278","https://openalex.org/W2171021135","https://openalex.org/W2110168283","https://openalex.org/W4392925893","https://openalex.org/W4282961189","https://openalex.org/W3030182682","https://openalex.org/W2129937169","https://openalex.org/W2053477304","https://openalex.org/W2244598191"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-03T00:00:00"}